Key facts
- Precision Cardiovascular appointed Brian Fahey, Ph.D., as an independent director.
- Fahey brings expertise in cardiovascular device development, clinical development, financing, and commercialization.
- Precision Cardiovascular is developing remote monitoring solutions for heart failure.
Precision Cardiovascular, a medical technology company focused on developing novel remote monitoring solutions for heart failure, announced the appointment of Brian Fahey, Ph.D., as an independent director to its Board of Directors. Fahey is a seasoned medtech entrepreneur with extensive experience in cardiovascular device development, clinical development, financing, and commercialization. His appointment is expected to bolster the company's strategic direction and operational capabilities in the rapidly evolving field of remote cardiac monitoring.